1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 22nd April 2024 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

A cognitive behavioural group treatment for somatic symptom disorder: a pilot study 2023 Jongsma et al

Discussion in 'Other psychosomatic news and research' started by Andy, Dec 2, 2023.

Tags:
  1. Andy

    Andy Committee Member

    Messages:
    21,999
    Location:
    Hampshire, UK
    NB: All authors are from McMaster Uni, Canada.

    Background
    Somatic symptom disorder (SSD) presents challenges to the healthcare system, including frequent medical visits, lack of symptom relief experienced by individuals with this condition, high associated medical costs, and patient dissatisfaction. This study examined the utility of a novel, low-barrier, brief cognitive behavioural therapy (CBT) group intervention for individuals with SSD.

    Methods
    Participants were referred by their mental health providers or self-referral. Each participant underwent a telephone screen and in-person psychological and neuropsychological screen. Two cycles of the CBT-based group (n = 30), each consisting of six weekly two-hour sessions, were facilitated at a large outpatient mental healthcare facility in Ontario, Canada. The final sample consisted of 13 individuals of whom 11 completed the treatment. Clinical outcome measures were administered pre-, mid- and post-group, including the Generalized Anxiety Disorder–7, Perceived Stress Scale–4, Pain Self-Efficacy Questionnaire, Pain Disability Index, Revised Illness Perception Questionnaire, and sections of the Patient Health Questionnaire. Six healthcare utilization metrics were collected from electronic medical records at six months pre- and post-group. Paired samples t-tests were used to examine pre- to post-group differences in participants’ somatic symptoms, psychological functioning, health, and degree of healthcare utilization.

    Results
    When comparing pre- and post- group, we observed reductions in the mean scores for somatic symptom severity, depressive symptomatology, anxiety, perceived stress, and perceived disability related to pain. The change in depressive symptomatology yielded a small effect size (d = 0.30). Further, we observed downward trends across participants’ pre- to post-group healthcare utilization, with small effect sizes observed for hospital admission (d = 0.36), days admitted to hospital (d = 0.47), and inpatient consults (d = 0.42). Differences between pre- and post-group measures of somatic symptom severity, psychological functioning, health, or healthcare utilization did not reach significance.

    Conclusions
    Current findings provide support for the potential effectiveness of an abbreviated CBT group for individuals with SSD in reducing psychiatric symptomatology. Further research is recommended, including randomized control trials, cost-benefit analyses, and comparisons between abbreviated versus longer-duration treatment programs for SSD.

    Open access, https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-023-05141-9
     
    Andy, Dec 2, 2023
    #1
    DokaGirl and Peter Trewhitt like this.
  2. Trish

    Trish Moderator Staff Member

    Messages:
    52,490
    Location:
    UK
    So basically they cherry picked a few results with small effect sizes and most of their questionnaires didn't given significant results.
    The conclusion should clearly be to scrap this treatment as a bad idea and move on. Instead the oh so predictable conclusion of 'potential effectiveness' and more research needed.
     
    Trish, Dec 2, 2023
    #2
    alktipping, Sean, SNT Gatchaman and 10 others like this.
  3. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    12,508
    Location:
    Canada
    A pilot study of a pragmatic trial for a pseudoscientific treatment model that has been tried hundreds of times before, including in large scale trial, and is, in fact, the current treatment model. A pilot study, which means trying something new for feasibility. The current treatment paradigm.

    But they call it "novel" and somehow a journal will publish it. And they even screened the participants, no doubt selecting for probability of reporting good outcomes regardless of actual outcome. Good grief, they are making a mockery of what it even means to be an expert.
    So the patients are just as ill, but have slightly given up on healthcare. Slightly, not significantly. And they report it a success anyway by talking about "support for the potential for effectiveness". About the current treatment paradigm, applied to millions of people for several decades.

    This is antiscience regression.
     
    Last edited: Dec 2, 2023
    rvallee, Dec 2, 2023
    #3
    alktipping, Sean, SNT Gatchaman and 4 others like this.
  4. Hutan

    Hutan Moderator Staff Member

    Messages:
    27,060
    Location:
    Aotearoa New Zealand
    Cherry-picked participants; cherry-picked outcomes. Another study in a long line of studies, this one with a hopelessly small sample size. And still there is no convincing case made for the treatment.

    Katherine Jongsma,
    Bri Susanna Darboh,
    Sasha Davis &
    Emily MacKillop

    It's worth recording the names of people who are willing to put their names to this prejudiced nonsense.

    Just because something is well-documented, doesn't make it true.

    I suppose the psychosomatic hypothesis is one western biomedical perspective, which again does not make it true. Highlighting it as such presumably is meant to make it more credible than describing it as 'vague hand-waving, patient-blaming pseudoscience', which it also is.

    This paragraph is notable.

    We've seen the psychosomatic hypothesis portrayed as something modern, a turning away from a narrow biological approach to considering the whole person and their environment - holistic, bio-psycho-social. We've seen objections to the wide application of SSD and functional disorder labels being framed as a prejudice against mental illness. We've seen SSD promoted as a feminist issue - that is, the stigma that people diagnosed with SSD experience has been described as a result of prejudice against women and their health conditions. Now it seems that any rejection of SSD is going to be painted as a lack of openness to the way that other cultures interpret emotional distress. These are all clever approaches that make clear arguments against the concept so much harder to make.
     
    Hutan, Dec 2, 2023
    #4
    shak8, alktipping, Sean and 5 others like this.
  5. Sean

    Sean Moderator Staff Member

    Messages:
    7,243
    Location:
    Australia
    Par excellence.
    They are just throwing everything and anything they can think of against the wall, hoping something, anything, will stick.
     
    Sean, Dec 3, 2023
    #5
    alktipping, Peter Trewhitt and Hutan like this.
  6. Midnattsol

    Midnattsol Moderator Staff Member

    Messages:
    3,613
    And as we know, there has never been cases of misattributions of "distress" as cause for illness.

    I remember and old acquaintance of mine. He became psychotic due to the consequences of undiagnosed celiac disease. When he cut gluten from his diet and treated the nutrient deficiencies his psychological symptoms disappeared.
     
    Midnattsol, Dec 3, 2023
    #6
    MEMarge, alktipping, rvallee and 6 others like this.
  7. bobbler

    bobbler Senior Member (Voting Rights)

    Messages:
    2,556
    I have no idea whether the two questionnaires are related (the one in this link is 15), however having read the following paper which includes Sharpe, Stone, Carson saying that the PHQ 15 doesn't identify people with unexplained symptoms better than chance I thought I'd do a quick google in case there were papers for which this reference might be relevant:

    Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a prospective cohort study of neurology outpatients - PubMed (nih.gov)

    Conclusions: Self-rated symptom count scores should not be used to identify patients with symptoms unexplained by disease."

    To discuss this paper, go to this thread:
    Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a ... study of neurology outpatients, 2015, Carson, Sharpe
     
    Last edited by a moderator: Apr 20, 2024
    bobbler, Apr 19, 2024
    #7
    Sean and Peter Trewhitt like this.

Share This Page